228063 - Hepatitis: Drugs (Answered)

Sir David Amess
To ask the Secretary of State for Health, what steps his Department and NHS England are taking to accelerate the access of hepatitis C patient to interferon-free medicines; and what estimate he has made of the number of patients who will commence treatment with such medicines in 2015.

George Freeman

The National Institute for Health and Care Excellence (NICE) is undertaking technology appraisals of several new drugs for the treatment of hepatitis C.

228011 - Contraceptives: Inflammatory Bowel Disease (Answered)

Jim Shannon
To ask the Secretary of State for Health, what discussions he has had with the Royal Colleges and the British Medical Association about possible links between use of the contraceptive pill and Crohn's disease.

George Freeman

A search of the Department’s Ministerial correspondence database has not identified any items of correspondence received since 1 January 2012 from the Royal Colleges and the British Medical Association about possible links between use of the contraceptive pill and Crohn's disease.

228014 - Fractures (Answered)

Jim Shannon
To ask the Secretary of State for Health, when he expects the NHS to introduce titanium splints to stabilise rib fractures.

George Freeman

In the absence of guidance from the National Institute for Health and Care Excellence (NICE), it is for National Health Service commissioners to take funding decisions on treatments based on an assessment of the available evidence.

228177 - Inflammatory Bowel Disease (Answered)

Mr Andrew Smith
To ask the Secretary of State for Health, what funding there has been from the public purse for research into treatment of (a) Crohn's disease and (b) ulcerative colitis in the last five years.

George Freeman

The following table shows expenditure on research relating to the treatment of Crohn’s disease and ulcerative colitis by the Medical Research Council, and by the National Institute for Health (NIHR) through its research programmes, research centres and units, and research fellowships.

£ million

228591 - Chronic Obstructive Pulmonary Disease (Answered)

Liz Kendall
To ask the Secretary of State for Health, how much was spent on the prescription of drugs to manage chronic obstructive pulmonary disease in the NHS in each year from 2009-10 to 2014-15.

George Freeman

The information requested cannot be provided as information on why a drug is prescribed is not collected. This is a particular issue for chronic obstructive pulmonary disease (COPD) as medicines used to treat COPD are also used to treat a number of other medical conditions, for example asthma.

228612 - Chronic Obstructive Pulmonary Disease (Answered)

Liz Kendall
To ask the Secretary of State for Health, how much the Government has allocated to development of new drugs and treatments for chronic obstructive pulmonary disease each year from 2009-10 to 2014-15.

George Freeman

228545 - Medicine: Research (Answered)

Mr Nicholas Brown
To ask the Secretary of State for Health, if he will make an assessment of the potential merits of using artificial human organs in medical testing.

George Freeman

The Medicines and Healthcare products Regulatory Agency (MHRA) is the competent authority responsible for authorising Clinical Trial Applications in the United Kingdom and for the issuing of Marketing Authorisations (licences) for medicinal products.

227804 - Tranquillisers (Answered)

Eric Ollerenshaw
To ask the Secretary of State for Health, whether the General Practice Research Database includes data on the prescribing of tranquillisers; and if he will use this database to calculate the number of patients with a long-term dependency on tranquillisers.

George Freeman

228610 - Hospitals: Cleaning Services (Answered)

Mr Jamie Reed
To ask the Secretary of State for Health, when the last deep clean of hospitals in the NHS took place.

George Freeman

Pages